Pfizer (NYSE:PFE) has been dismissed as a defendant in a major federal lawsuit alleging generic drug price fixing. The court ...
Pfizer Inc. was able to dodge litigation alleging it colluded with other pharmaceutical companies to fix the price of generic ...
By Jonathan Stempel June 24 (Reuters) - Pfizer has been dismissed as a defendant in a sweeping antitrust lawsuit in which ...
By Michael Erman June 22 (Reuters) - Pfizer said on Monday that one of the key experimental drugs it picked up in its $43 ...
Pfizer remains in focus as healthcare stays steady during market weakness, with drug-pricing questions shaping the ...
Pfizer announced yesterday it was settling an epic legal battle with the Indian drugmaker Ranbaxy Laboratories that will keep generic versions of the best-selling cholesterol medicine Lipitor off the ...
FILE - In this June 14, 2011 file photo, the drug Lipitor is displayed at Medco Health Solutions Inc., in Willingboro, N.J. Cholesterol blockbuster Lipitor is so valuable to Pfizer Inc. that the drug ...
Pfizer is struggling right now, leaving it in the Wall Street doghouse; it won't be there forever.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results